Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase

The haematopoietic protein tyrosine phosphatase (HePTP) is a negative regulator of the MAP kinases Erk1, Erk2 and p38. HePTP binds to these kinases through a kinase-interaction motif (KIM) in its non-catalytic amino terminus and inactivates them by dephosphorylating the critical phosphorylated tyrosine residue in their activation loop. Here we show that cyclic-AMP-dependent protein kinase (PKA) phosphorylates serine residue 23 in the KIM of HePTP in vitro and in intact cells. This modification reduces binding of MAP kinases to the KIM, an effect that is prevented by mutation of serine 23 to alanine. The PKA-mediated release of MAP kinase from HePTP is sufficient to activate the kinase and to induce transcription from the c-fos promoter. Expression of a HePTP serine-23-to-alanine mutant inhibits MAP-kinase dissociation and activation and induction of transcription from the c-fos promoter. We conclude that HePTP not only controls the activity of MAP kinases, but also mediates crosstalk between the cAMP system and the MAP-kinase cascade.

[1]  P. Lombroso,et al.  Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Torgersen,et al.  Selective Activation of cAMP-dependent Protein Kinase Type I Inhibits Rat Natural Killer Cell Cytotoxicity* , 1997, The Journal of Biological Chemistry.

[3]  T. Mustelin,et al.  Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor/CD3-induced activation of the mitogen-activated kinase Erk2. , 1996, European journal of biochemistry.

[4]  C. Moskaluk,et al.  PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. , 1993, Science.

[5]  S. A. Rudolph,et al.  Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by a cAMP-dependent pathway. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Kobayashi,et al.  Serine Phosphorylation-dependent Association of the Band 4.1-related Protein-tyrosine Phosphatase PTPH1 with 14-3-3β Protein* , 1997, The Journal of Biological Chemistry.

[7]  W. Swaim,et al.  Aggregation of IgE Receptors in Rat Basophilic Leukemia 2H3 Cells Induces Tyrosine Phosphorylation of the Cytosolic Protein-tyrosine Phosphatase HePTP (*) , 1995, The Journal of Biological Chemistry.

[8]  Hong Sun,et al.  MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.

[9]  S. Cook,et al.  Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.

[10]  N. Tonks,et al.  PTP‐PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. , 1994, The EMBO journal.

[11]  K. Luo,et al.  Transfer of proteins to membranes facilitates both cyanogen bromide cleavage and two-dimensional proteolytic mapping. , 1990, Oncogene.

[12]  S. Keyse,et al.  Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase , 1992, Nature.

[13]  P. Rabinovitch,et al.  Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. , 1986, Journal of immunology.

[14]  E. Aandahl,et al.  Protein kinase A type I antagonist restores immune responses of T cells from HIV‐infected patients , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Arthur Weiss,et al.  Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor , 1992, Cell.

[16]  T. Mustelin,et al.  The next wave: protein tyrosine phosphatases enter T cell antigen receptor signalling. , 1999, Cellular signalling.

[17]  T. Mustelin,et al.  Inhibition of T Cell Signaling by Mitogen-activated Protein Kinase-targeted Hematopoietic Tyrosine Phosphatase (HePTP)* , 1999, The Journal of Biological Chemistry.

[18]  M. Muda,et al.  Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. , 1998, Science.

[19]  Robert A. Lewis,et al.  CYCLIC AMP-DEPENDENT PROTEIN KINASE ACTIVATION* , 1981 .

[20]  J. Frost,et al.  Regulation of the MAP kinase cascade. , 1994, Cellular & molecular biology research.

[21]  H. Huitfeldt,et al.  Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. , 1994, Science.

[22]  A. Ullrich,et al.  PTP‐SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal‐regulated kinases ERK1 and ERK2 by association through a kinase interaction motif , 1998, The EMBO journal.

[23]  L. Cantley,et al.  Regulation of the Lck SH2 Domain by Tyrosine Phosphorylation* , 1996, The Journal of Biological Chemistry.

[24]  I. Grants,et al.  Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and ionomycin. , 1992, Cellular immunology.

[25]  J. Partanen,et al.  The human p50csk tyrosine kinase phosphorylates p56lck at Tyr‐505 and down regulates its catalytic activity. , 1992, The EMBO journal.

[26]  T. Mustelin,et al.  Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk. , 1997, European journal of biochemistry.

[27]  T. Mustelin,et al.  Involvement of Phosphatidylinositol 3-Kinase in NFAT Activation in T Cells* , 1997, The Journal of Biological Chemistry.

[28]  E. Smeland,et al.  Cyclic AMP‐dependent protein kinase (cAK) in human B cells: co‐localization of type I cAK (RIα2C2) with the antigen receptor during anti‐immunoglobulin‐induced B cell activation , 1996, European journal of immunology.

[29]  P. Lombroso,et al.  A Neuronal Protein Tyrosine Phosphatase Induced by Nerve Growth Factor (*) , 1995, The Journal of Biological Chemistry.

[30]  Y. Watanabe,et al.  Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase. , 1995, Gene.

[31]  M. Minden,et al.  Cloning and expression of an inducible lymphoid‐specific, protein tyrosine phosphatase (HePTPase) , 1992, European journal of immunology.

[32]  Taosheng Chen,et al.  Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. , 1999, Cancer research.

[33]  K. Tasken,et al.  Specificity in the cAMP/PKA signaling pathway. Differential expression,regulation, and subcellular localization of subunits of PKA. , 2000, Frontiers in bioscience : a journal and virtual library.

[34]  T. Mustelin,et al.  Negative Regulation of T Cell Antigen Receptor Signal Transduction by Hematopoietic Tyrosine Phosphatase (HePTP)* , 1998, The Journal of Biological Chemistry.

[35]  S. Uddin,et al.  Prostaglandin E2 modulation of p59fyn tyrosine kinase in T lymphocytes during sepsis. , 1998, Journal of immunology.

[36]  T. Onytiganis Development of ''substrate-trapping'' mutants to identify physiological substrates of protein tyrosine phosphatases , 1997 .

[37]  M. Muda,et al.  MKP-3, a Novel Cytosolic Protein-tyrosine Phosphatase That Exemplifies a New Class of Mitogen-activated Protein Kinase Phosphatase (*) , 1996, The Journal of Biological Chemistry.

[38]  T. Hamaoka,et al.  cDNA Cloning and Characterization of a Novel Receptor-type Protein Tyrosine Phosphatase Expressed Predominantly in the Brain (*) , 1995, The Journal of Biological Chemistry.

[39]  T. Mustelin,et al.  Lymphocyte activation: the coming of the protein tyrosine phosphatases. , 1998, Frontiers in bioscience : a journal and virtual library.

[40]  E. Krebs,et al.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Kammer The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. , 1988, Immunology today.

[42]  G. Kammer,et al.  Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. , 1994, The Journal of clinical investigation.

[43]  M. Montminy,et al.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene , 1987, Nature.

[44]  A. Sharrocks,et al.  Integration of MAP kinase signal transduction pathways at the serum response element. , 1995, Science.

[45]  J. Scott Cyclic nucleotide-dependent protein kinases. , 1991, Pharmacology & therapeutics.

[46]  Lin Chen,et al.  Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth , 1993, Molecular and cellular biology.

[47]  B. Kemp,et al.  Protein kinase recognition sequence motifs. , 1990, Trends in biochemical sciences.

[48]  T. Yokota,et al.  Bruton’s Tyrosine Kinase-mediated Interleukin-2 Gene Activation in Mast Cells , 1998, The Journal of Biological Chemistry.

[49]  S. Døskeland,et al.  Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3',5'-cyclic adenosine monophosphate on cell replication in human T lymphocytes. , 1992, The Journal of biological chemistry.